James Lee, MD, is a physician-scientist focused on basic and translational research in cancer immunotherapy. Through his training thus far, he has developed significant research experience investigating the primary tolerogenic mechanisms of immunotherapy resistance relevant to both chimeric antigen receptor (CAR) T-cell and checkpoint inhibitor treatment modalities. He received early, rigorous translational research training when … Continue reading James Lee, MD